Franklin Street Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

Franklin Street Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-84,750	Closed	-$1.14M	–	206
2016 Q2	$1.14M	Sell	84,750 -18,775	-18%	-$274K	0.22%	93
2016 Q1	$1.58M	Sell	103,525 -27,150	-21%	-$426K	0.31%	83
2015 Q4	$2.59M	Sell	130,675 -450	-0.3%	-$8.55K	0.51%	60
2015 Q3	$2.28M	Sell	131,125 -13,000	-9%	-$265K	0.45%	67
2015 Q2	$2.91M	Buy	144,125 +28,200	+24%	+$544K	0.52%	60
2015 Q1	$2.04M	Buy	115,925 +23,250	+25%	+$396K	0.37%	74
2014 Q4	$1.51M	Buy	92,675 +48,725	+111%	+$894K	0.29%	89
2014 Q3	$970K	Buy	43,950 +23,800	+118%	+$487K	0.18%	112
2014 Q2	$405K	Buy	+20,150	New	+$341K	0.08%	165

Other funds holding AMRI

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Franklin Street Advisors's AMRI Position: Q3 2016 in Review

Franklin Street Advisors sold out of Albany Molecular Research Inc (AMRI) in Q3 2016, closing a stake of 84,750 shares — an estimated $1.14M sold.

Franklin Street Advisors first reported a position in AMRI in Q2 2014 and held it in 9 quarters. The position peaked at $2.91M in Q2 2015. 137 funds tracked by Wall St. Rank hold AMRI as of Q3 2016.

Franklin Street Advisors reported no remaining Albany Molecular Research Inc position as of Q3 2016 after selling out during the quarter.
Franklin Street Advisors sold 84,750 Albany Molecular Research Inc shares in Q3 2016, an estimated $1.14M.
Franklin Street Advisors first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 9 quarters.
Franklin Street Advisors's Albany Molecular Research Inc position peaked at $2.91M in Q2 2015.
137 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2016.

Based on Franklin Street Advisors's 13F filing for Q3 2016, filed 5 Oct 2016.